Inner Mongolia Anzhou Pharmaceutical Co., Ltd. is a modern pharmaceutical enterprise that specializes in the research, development, production, and sale of high-quality pharmaceutical products. In recent years, the company has been committed to improving its production processes and adopting more advanced technologies to reduce production costs, save energy, and minimize environmental pollution.
One of the major projects undertaken by the company is the transformation of its existing chemical synthesis process to an advanced enzymatic process for the production of ceftriaxone sodium. This initiative aims to reduce production costs while also improving production efficiency. This project is being implemented in the company's empty second workshop, which will be converted for this purpose.
Another project that the company is currently working on involves the renovation of its existing imidazole formaldehyde production line. The project includes the conversion of some of the existing equipment, such as the 1500L reaction vessel, to a 1000L reaction vessel, and the addition of a stainless-steel pressure filter. This will allow the production of metronidazole and hydrochloric acid salaridoxin to be conducted under safer conditions and with a lower risk of reaction. Additionally, the project also involves the installation of a spiral plate condenser, a precision filter, a drip tank, and other equipment to improve the production process.
Lastly, as the Phase 2 production site has not yet been completed, the company plans to adjust the production of levofloxacin to the third workshop and the production of ciprofloxacin to the Phase 2 production line. The company is adopting advanced energy-saving and environmentally-friendly technologies and equipment to achieve automation and intelligence in the production process.
In conclusion, Inner Mongolia Anzhou Pharmaceutical Co., Ltd. is committed to continuously improving its production processes through innovative technologies and efficient management practices. With the ongoing projects mentioned above, the company will be able to produce high-quality pharmaceutical products at a lower cost while minimizing the impact on the environment.